A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer

European Radiology

Volumn 22, Issue 7, 2012, Pages 1537-1546

  Kim, Yoo Na ^a,c   Yi, Chin A ^a   Lee, Kyung Soo ^a   Kwon, O Jung ^a   Lee, Ho Yun ^a   Kim, Byung Tae ^a   Choi, Joon Young ^a   Kim, Seon Woo ^b   Chung, Man Pyo ^a   Han, Joungho ^a   Kim, Tae Sung ^a   Chung, Myung Jin ^a   Shim, Young Mog ^a  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Diffusion weightedMR imaging (DWI); Keywords Magnetic resonance imaging (MRI); Non small cell lung cancer (NSCLC); PET CT. Lung cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE;

EID: 84864676620     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2388-3     Document Type: Article

References (38)

1. Jemal A, Chu KC, Tarone RE (2001) Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst 93:277-283
2. Tanaka F, Yanagihara K, Otake Y et al (2000) Surgery for nonsmall cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend. Eur J Cardiothorac Surg 18:147-155
3. McLoud TC, Bourgouin PM, Greenberg RW et al (1992) Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 182:319-323
4. Seely JM, Mayo JR, Miller RR, Muller NL (1993) T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 186:129-132
5. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ (1996) Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 111:642-648
6. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR (2001) Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 120:521-527
7. Shim SS, Lee KS, Kim BT et al (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236:1011-1019
8. Toloza EM, Harpole L, McCrory DC (2003) Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123:137S-146S
9. Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA (2010) The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer. Interact Cardiovasc Thorac Surg 10:200-203
10. Kim YK, Lee KS, Kim BT et al (2007) Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 109:1068-1077
11. Bille A, Pelosi E, Skanjeti A et al (2009) Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 36:440-445
12. Gupta NC, Graeber GM, Bishop HA (2000) Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (3 cm) lymph node lesions. Chest 117:773-778
13. Patz EF Jr, Lowe VJ, Hoffman JM et al (1993) Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188:487-490
14. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP (1993) Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 104:997-1002
15. Nakayama J, Miyasaka K, Omatsu T et al (2010) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 34:1-8
16. Ohno Y, Hatabu H, Takenaka D et al (2004) Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 231:872-879
17. Ohno Y, Koyama H, Nogami M et al (2007) STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging 26:1071-1080
18. Kim HY, Yi CA, Lee KS et al (2008) Nodal metastasis in nonsmall cell lung cancer: accuracy of 3.0-T MR imaging. Radiology 246:596-604
19. Le Bihan D, Delannoy J, Levin RL (1989) Temperature mapping with MR imaging of molecular diffusion: application to hyperthermia. Radiology 171:853-857
20. Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102-125
21. Hasegawa I, Boiselle PM, Kuwabara K, Sawafuji M, Sugiura H (2008) Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging. J Thorac Imaging 23:157-161
22. Kosucu P, Tekinbas C, Erol M et al (2009) Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging. J Magn Reson Imaging 30:292-297
23. Nomori H, Mori T, Ikeda K et al (2008) Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 135:816-822
24. Eiber M, Beer AJ, Holzapfel K et al (2010) Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 45:15-23
25. Padhani AR, Miles KA (2010) Multiparametric imaging of tumor response to therapy. Radiology 256:348-364
26. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P (2009) The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 4:568-577
27. Akduman EI, Momtahen AJ, Balci NC, Mahajann N, Havlioglu N, Wolverson MK (2008) Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging. Acad Radiol 15:641-646
28. Bennett BM (1972) On comparisons of sensitivity, specificity and predictive value of a number of diagnostic procedures. Biometrics 28:793-800
29. Takenaka D, Ohno Y, Hatabu H et al (2002) Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratorytriggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol 44:216-224
30. Yi CA, Shin KM, Lee KS et al (2008) Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 248:632-642
31. Sundaram M, McGuire MH, Schajowicz F (1987) Soft-Tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. AJR Am J Roentgenol 148:1247-1250
32. Chakraborti KL, Jena A (1997) MR evaluation of the mediastinal lymph nodes. Indian J Chest Dis Allied Sci 39:19-25
33. Glazer GM, Orringer MB, Chenevert TL et al (1988) Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. Radiology 168:429-431
34. Wiener JI, Chako AC, Merten CW, Gross S, Coffey EL, Stein HL (1986) Breast and axillary tissue MR imaging: correlation of signal intensities and relaxation times with pathologic findings. Radiology 160:299-305
35. Bottomley PA, Hardy CJ, Argersinger RE, Allen-Moore G (1987) A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? Med Phys 14:1-37
36. Rowley HA, Grant PE, Roberts TP (1999) Diffusion MR imaging. Theory and applications. Neuroimaging Clin N Am 9:343-361
37. Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622-1635
38. Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A (2006) Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 16:1468-1477